Montenegro vs Trinidad and Tobago: The number of people with susceptibility test result for rifampicin
Montenegro
55
in 2021
Trinidad and Tobago
57
in 2021
Montenegro rank
121st
Trinidad and Tobago rank
120th
The number of people with susceptibility test result for rifampicin over time
- Montenegro
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 57 against 55 in Montenegro, a difference of 2.
Across all 5 years both countries report, Trinidad and Tobago has been ahead every year.
Montenegro ranks 121st and Trinidad and Tobago ranks 120th of 155 countries.
Trinidad and Tobago has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Montenegro | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 57 | 102.67 | 45.67 | Trinidad and Tobago |
| 2020s | 42 | 74.5 | 32.5 | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Montenegro or Trinidad and Tobago?
- Trinidad and Tobago, at 57 against 55 in Montenegro as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Montenegro and Trinidad and Tobago?
- 2, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Montenegro and Trinidad and Tobago?
- 5 years are reported by both, from 2017 to 2021.
- How do Montenegro and Trinidad and Tobago rank globally for the number of people with susceptibility test result for rifampicin?
- Montenegro ranks 121st and Trinidad and Tobago ranks 120th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.